Microbot Medical Inc. (MBOT) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MBOT Revenue Growth
MBOT Revenue Analysis (2013–2024)
As of May 8, 2026, Microbot Medical Inc. (MBOT) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, MBOT's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $1.2 million in 2013.
When compared to Healthcare sector peers including SSYS (-3.7% YoY), ISRG (+21.4% YoY), and NVCR (+8.5% YoY). Compare MBOT vs SSYS →
MBOT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MBOTCurrent | $0 | - | - | - | |
 SSYS | $551M | -3.7% | +1.1% | -10.7% | |
 ISRG | $10.1B | +21.4% | +18.2% | 29.3% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% |
MBOT Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-91,000 | - | $-11,625,000 | - |
| 2023 | $0 | - | $-106,000 | - | $-9,855,000 | - |
| 2022 | $0 | - | $0 | - | $-13,281,000 | - |
| 2021 | $0 | - | $0 | - | $-11,357,000 | - |
| 2020 | $0 | - | $0 | - | $-9,089,000 | - |
| 2019 | $0 | - | $-84,000 | - | $-7,240,000 | - |
| 2018 | $0 | - | $-54,000 | - | $-7,244,000 | - |
| 2017 | $0 | - | $-21,000 | - | $-5,267,000 | - |
| 2016 | $0 | -100.0% | $-10,000 | - | $-9,635,000 | - |
| 2015 | $117K | -88.4% | $117K | 100.0% | $-36,720,000 | -31384.6% |
See MBOT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MBOT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MBOT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMBOT — Frequently Asked Questions
Quick answers to the most common questions about buying MBOT stock.
Is MBOT's revenue growth accelerating or slowing?
MBOT TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is MBOT's long-term revenue growth rate?
Microbot Medical Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is MBOT's revenue distributed by segment?
MBOT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.